Liquid Biopsy Growth Exosome Diagnostics specializes in minimally invasive molecular diagnostics using exosome-based liquid biopsies for cancer and other diseases, indicating sales opportunities in clinical labs and hospitals aiming to adopt non-invasive diagnostic workflows.

Prostate Test Expansion The ExoDx Prostate Test At-Home Collection Kit demonstrates experience in consumer-accessible collection solutions, suggesting partnerships or channel strategies to extend at-home or primary-care diagnostics, increasing test adoption in urology and primary care settings.

Strategic Partnerships Former acquisition by Bio-Techne and collaboration history with pharmaceutical R&D, such as Intezyne, indicate readiness for co-development, validation studies, and companion diagnostics opportunities with pharma and biotech partners.

Regulatory & Compliance ISO 13485 and HIPAA alignment point to strong quality management and data protection, enabling conversations with regulated labs, CROs, and multi-site deployments that require compliant diagnostic solutions.

Scale & Outreach Revenue range and substantial funding suggest a scalable commercial footprint; leverage this for multi-country or large-hospital system deployments, while highlighting potential upsell of exosome-based assays and workflow integration services.